Wag! Group Co. ((the ", Company" or "Wag!", NASDAQ:PET), which strives to be the #1 platform for busy Pet Parents, offering on-demand access to 5-star pet care, pet insurance options, and expert pet advice, today announced that members …
– Clinical trial in progress to be presented for Phase 1a/b study investigating AB248 alone and in combination with pembrolizumab in patients with advanced solid tumors – – Preclinical data for cis-targeted IL-2 and IL-21 cytokines that selectively …
INDIANAPOLIS, March 14, 2023 /PRNewswire/ -- Eli Lilly and Company LLY today announced that data from its oncology portfolio will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, April 14 – 19, 2023. …
BlackRock Advisors, LLC ("BlackRock") will host a conference call on Wednesday, March 15, 2023 at 2:00pm ET featuring Phil Ruvinsky, Head of BlackRock's U.S. Growth Team and the Portfolio Manager for BlackRock Innovation and Growth Trust (…
Eleven abstracts accepted for poster presentation highlight company's differentiated antibody drug conjugate, multispecific antibody, and clinical product candidates Management will host a conference call on April 18th at 6:30 pm Eastern Standard Time …
- Interim results from Phase 2 innovaTV 207 trial of tisotumab vedotin in head and neck cancer to be presented - - Initial Phase 1 dose-escalation data for SEA-TGT monotherapy in advanced malignancies to be disclosed - - Preclinical data and discovery …
Xencor, Inc. XNCR, a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will present preclinical data on novel XmAb® CD28 bispecific antibody …
SOUTH SAN FRANCISCO, Calif., March 14, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. IDYA, a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced publication …
HALIFAX, NS / ACCESSWIRE / March 14, 2023 / Today, MedMira Inc. (MedMira) MIR provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test. The Company has successfully started its …
PRINCETON, NJ / ACCESSWIRE / March 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. SONN ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that data from the company- …
NORWOOD, Mass., March 14, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. CRBP ("Corbus" or the "Company"), a precision oncology company, today announced that an abstract highlighting pre-clinical data for CRB-601, its avβ8 …
Flare Therapeutics Inc., a private biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced that it will give an oral presentation highlighting the discovery of its clinical …
- Reports $64.1 Million of Revenue, Growth of 24% Year-Over-Year - Insurance Segment continues strong growth, with atypical fourth-quarter weather impacting Adjusted EBITDA SEATTLE, March 14, 2023 (GLOBE NEWSWIRE) -- Porch Group, Inc. ("Porch Group…
Awarded $448 million contract with the United States Navy as part of joint venture; Year-to-date contract wins total over $582 million Announces three point strategic plan to continuously improve financial performance HOUSTON, March 14, 2023 (GLOBE …
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. ERAS, a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced …
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 14, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises First Republic Bank (“First Republic” or “the Company”) (NYSE: FRC) investors that the …
Accelerating the March Toward Health Equity WASHINGTON , DC, UNITED STATES, March 14, 2023 /EINPresswire.com/ -- The National Medical Association (NMA) is hosting its annual National Colloquium on African American Health, March 24-27, 2023, in …
SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancers, today announced the acceptance of two late-breaking abstracts …
BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. SNSE, an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, will present new preclinical data on SNS-103, a …
QUEBEC CITY, March 14, 2023 (GLOBE NEWSWIRE) -- Robex Resources Inc. RBXRB)) ("Robex" or the "Company") is pleased to announce the ramp up of its exploration drilling campaign for 2023. Highlights Minimum 50,000 meters of RC drilling …
04 days 16:47:02
